VERA Form 144: Proposed Sale of 18,500 Shares

VERA affiliate notified a proposed sale of 18,500 shares through a Form 144 filing.

Rhea-AI Filing Summary

VERA affiliate notified a proposed sale of 18,500 shares through a Form 144 filing.

The filing states 18,500 common shares are to be sold on 05/12/2026 following an exercise of stock options for cash. The excerpt also lists prior 10b5-1 sales by Marshall Fordyce: 22,951 shares on 04/14/2026 and 16,925 shares on 02/23/2026.

Insights

Securities Compliance Counsel

Form 144 notifies a planned resale of 18,500 shares tied to option exercise.

The filing lists an exercise of stock options with sale method labeled as cash on 05/12/2026. This form is a regulatory notice required for affiliate resales when certain conditions are met.

Cash‑flow treatment is stated as cash for the immediate sale; preceding 10b5-1 sales on 04/14/2026 and 02/23/2026 are shown as historical dispositions. Subsequent public filings may disclose completion details.

Key Figures

Proposed shares to sell: 18,500 shares Prior 10b5-1 sale (Apr): 22,951 shares Prior 10b5-1 sale (Feb): 16,925 shares +2 more

5 metrics

Proposed shares to sell 18,500 shares proposed sale tied to option exercise on 05/12/2026

Prior 10b5-1 sale (Apr) 22,951 shares 10b5-1 sale on 04/14/2026 by Marshall Fordyce

Prior 10b5-1 sale (Feb) 16,925 shares 10b5-1 sale on 02/23/2026 by Marshall Fordyce

Proceeds reported (Apr sale) $1,011,050.49 aggregate proceeds for 22,951 shares on 04/14/2026

Proceeds reported (Feb sale) $710,577.51 aggregate proceeds for 16,925 shares on 02/23/2026

Key Terms

Form 144, 10b5-1, exercise of stock options

3 terms

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 regulatory

"10b5-1 Sales for MARSHALL FORDYCE"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

exercise of stock options financial

"Exercise of Stock Options | Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does VERA's Form 144 disclose about the 05/12/2026 sale?

It discloses a proposed sale of 18,500 common shares tied to an exercise of stock options with proceeds described as cash. The filing lists the intended sale date as 05/12/2026 and identifies the sale method as option exercise and cash disposition.

Who reported the prior 10b5-1 sales shown in the Form 144 for VERA?

The filing lists prior 10b5-1 sales attributed to Marshall Fordyce. It shows 22,951 shares sold on 04/14/2026 and 16,925 shares sold on 02/23/2026, with aggregate proceeds noted for each transaction.

Does the Form 144 state how proceeds will be used for the VERA sale?

The excerpt states the securities are sold following an exercise of stock options and lists the payment method as cash. The filing does not include a use‑of‑proceeds allocation or additional disposition instructions in the provided excerpt.

Is the 18,500‑share amount in the Form 144 an executed sale or a proposed resale?

The Form 144 provides notice of a proposed resale of 18,500 shares associated with an option exercise and lists the intended sale date 05/12/2026. Completion status and transaction settlement details are not included in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/12/2026 - 04:33 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001859453
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VERA THERAPEUTICS INC
SEC File Number	001-40407
Address of Issuer	2000 Sierra Point Parkway, Suite 1200 Brisbane CALIFORNIA 94005
Phone	6507700077
Name of Person for Whose Account the Securities are To Be Sold	MARSHALL FORDYCE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	18500	677285.00	71782904	05/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/12/2026	Exercise of Stock Options	Issuer			18500	05/12/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MARSHALL FORDYCE 2000 Sierra Point Parkway, Suite 1200 Brisbane CA 94005	Common	04/14/2026	22951	1011050.49
MARSHALL FORDYCE 2000 Sierra Point Parkway, Suite 1200 Brisbane CA 94005	Common	02/23/2026	16925	710577.51

144: Remarks and Signature

Remarks
Date of Notice	05/12/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	01/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Marshall Fordyce
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)